146 related articles for article (PubMed ID: 37477348)
1. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Kour A; Tiwari V; Aggarwal N; Sekhar Panda H; Kumar A; Tiwari S; Chauhan VS; Shukla S; Panda JJ
Nanoscale; 2023 Aug; 15(30):12748-12770. PubMed ID: 37477348
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent Dopamine-Tryptophan Nanocomposites as Dual-Imaging and Antiaggregation Agents: New Generation of Amyloid Theranostics with Trimeric Effects.
Sharma M; Tiwari V; Shukla S; Panda JJ
ACS Appl Mater Interfaces; 2020 Sep; 12(39):44180-44194. PubMed ID: 32870652
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
4. Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model.
Kour A; Dube T; Kumar A; Panda JJ
Bioconjug Chem; 2022 Feb; 33(2):397-410. PubMed ID: 35120290
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS.
Vicente-Zurdo D; Gómez-Gómez B; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Chim Acta; 2023 Apr; 1249():340949. PubMed ID: 36868776
[TBL] [Abstract][Full Text] [Related]
7. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
8. Self-Fluorescent Lone Tryptophan Nanoparticles as Theranostic Agents Against Alzheimer's Disease.
Sharma M; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S; Panda JJ
ACS Appl Mater Interfaces; 2022 Mar; 14(11):13079-13093. PubMed ID: 35263093
[TBL] [Abstract][Full Text] [Related]
9. The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats.
Hashemi-Firouzi N; Afshar S; Asl SS; Samzadeh-Kermani A; Gholamigeravand B; Amiri K; Majidi M; Shahidi S
Metab Brain Dis; 2022 Dec; 37(8):3011-3021. PubMed ID: 36271966
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
Vicente-Zurdo D; Rodríguez-Blázquez S; Gómez-Mejía E; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2022 Nov; 414(26):7573-7584. PubMed ID: 35982253
[TBL] [Abstract][Full Text] [Related]
11. Arginine-α, β-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery.
Singh PK; Chibh S; Dube T; Chauhan VS; Panda JJ
Pharm Res; 2018 Jan; 35(2):35. PubMed ID: 29362936
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer's Disease by Regulating Sirt1/miRNA-134/GSK3β Expression.
Abozaid OAR; Sallam MW; El-Sonbaty S; Aziza S; Emad B; Ahmed ESA
Biol Trace Elem Res; 2022 Dec; 200(12):5104-5114. PubMed ID: 35059981
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Yang L; Wang W; Chen J; Wang N; Zheng G
J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
[TBL] [Abstract][Full Text] [Related]
14. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
15. Administration of Selenium Nanoparticles Reverses Streptozotocin-Induced Neurotoxicity in the male rats.
Gholamigeravand B; Shahidi S; Amiri I; Samzadeh-Kermani A; Abbasalipourkabir R; Soleimani Asl S
Metab Brain Dis; 2021 Aug; 36(6):1259-1266. PubMed ID: 33826055
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
17. Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1-42 Polymerization.
Yuan N; Ye L; Sun Y; Wu H; Xiao Z; Fu W; Chen Z; Pei Y; Min Y; Wang D
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108834
[TBL] [Abstract][Full Text] [Related]
18. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
19. Biogenic Selenium Nanoparticles Attenuate Aβ
Qiao L; Chen Y; Dou X; Song X; Xu C
Neurotox Res; 2022 Dec; 40(6):1869-1881. PubMed ID: 36435923
[TBL] [Abstract][Full Text] [Related]
20. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
